Icahn School of Medicine at Mount Sinai
Myeloid Malignancy Workshop
Icahn School of Medicine at Mount Sinai
Strategies to Overcome Immune Dysregulation in MPNs
FEATURING
Cansu Cimen Bozkus
- 2 views
- July 2, 2024
Icahn School of Medicine at Mount Sinai
Boosting MHC:TCR Interactions in AML
FEATURING
Iannis Aifantis
- 1 view
- July 2, 2024
Icahn School of Medicine at Mount Sinai
Therapeutic Targeting of RNA Splicing Factor Mutant Leukemias
FEATURING
Omar Abdel-Wahab
- 2 views
- July 2, 2024
Icahn School of Medicine at Mount Sinai
Stem Cell Pathways, Aging, and Cancer Evolution in MPN
FEATURING
Catriona Jamieson
- 8 views
- July 2, 2024
Icahn School of Medicine at Mount Sinai
Targeting Mutant Calreticulin in MPN
FEATURING
Ann Mullally
- 1 view
- July 2, 2024
Icahn School of Medicine at Mount Sinai
BMT for MDS: Updates and Tricky Case Discussion
FEATURING
Amy DeZern
- 143 views
- June 20, 2024
Icahn School of Medicine at Mount Sinai
Emerging Landscape of Treating Anemia in LR-MDS
FEATURING
Rami Komrokji
- 62 views
- June 18, 2024
Icahn School of Medicine at Mount Sinai
State-of-the-Art Management of Systemic Mastocytosis
FEATURING
Daniel J. DeAngelo
- 45 views
- June 18, 2024
Icahn School of Medicine at Mount Sinai
MDS: Prospects for Individualized Therapy With Targeted Therapies Post-HMA Failure
FEATURING
Lewis Silverman
- 60 views
- June 16, 2024
Icahn School of Medicine at Mount Sinai
Integrating Targeted Therapies in AML
FEATURING
Hagop Kantarjian
- 311 views
- May 31, 2024
- 3
Icahn School of Medicine at Mount Sinai
BPDCN: Current and Future Directions
FEATURING
Naveen Pemmaraju
- 7 views
- May 31, 2024